Evommune, Inc. (EVMN)
Since Dec 11, 2025, Evommune, Inc. (EVMN) has reported earnings 4 times. On average the shares move ±5.16% post-earnings, with a positive reaction 75.0% of the time. Its largest post-earnings gain was +5.62% (Mar 05, 2026) and its largest decline was -8.53% (Dec 11, 2025). The next earnings report is predicted for 2026-12-07 (estimated).
Earnings reactions
How EVMN moved on each past earnings report.
Earnings Impact
Total Earnings
4
Avg Abs. Movement
±5.16%
Positive %
75.0%
Negative %
25.0%
Historical Earnings Statistics
| Date | Timing | Earnings move | SEC Filing |
|---|---|---|---|
| Aug 06, 2026 | ☽ POST | +5.35% | open_in_new |
| May 07, 2026 | ☽ POST | +1.13% | open_in_new |
| Mar 05, 2026 | ☽ POST | +5.62% | open_in_new |
| Dec 11, 2025 | ☽ POST | -8.53% | open_in_new |
Earnings Count
4
Total earnings in dataset
Avg Abs. Movement
±5.16%
Avg % price change on earnings
Institutional ownership
Holdings as of Jun 30, 2026 · SEC 13-F
SEC Filing Types
Recent SEC Filings
10 most recent| Form | Date Filed | View on EDGAR |
|---|---|---|
| SCHEDULE 13G/A | 20260814 | open_in_new SEC.gov |
| SCHEDULE 13G | 20260814 | open_in_new SEC.gov |
| 10-Q | 20260806 | open_in_new SEC.gov |
| 424B3 | 20260806 | open_in_new SEC.gov |
| 8-K | 20260806 | open_in_new SEC.gov |
| 8-K | 20260730 | open_in_new SEC.gov |
| SCHEDULE 13G | 20260716 | open_in_new SEC.gov |
| 4 | 20260710 | open_in_new SEC.gov |
| 4 | 20260708 | open_in_new SEC.gov |
| 424B3 | 20260629 | open_in_new SEC.gov |
Frequently asked about EVMN earnings
When does Evommune, Inc. report earnings next? expand_more
Evommune, Inc. (EVMN)'s next earnings date is estimated for 2026-12-07. This is a prediction based on its historical quarterly reporting pattern, not a company-confirmed date.
How much does EVMN stock move after earnings? expand_more
Over 4 reports, EVMN has moved an average of ±5.16% the session after earnings, closing higher 75.0% of the time.
What was EVMN's biggest post-earnings move? expand_more
EVMN's largest post-earnings gain on record was +5.62% on Mar 05, 2026, and its largest decline was -8.53% on Dec 11, 2025.
Where can I find Evommune, Inc.'s SEC filings? expand_more
All of Evommune, Inc.'s SEC filings — 10-K, 10-Q, 8-K and more — are listed in the SEC filings section on this page, each linking to the original document on SEC.gov.
Sector peers
- Aardvark Therapeutics, Inc. (AARD) earnings history chevron_right
- AbCellera Biologics Inc. Common Shares (ABCL) earnings history chevron_right
- ABEONA THERAPEUTICS INC. (ABEO) earnings history chevron_right
- Acumen Pharmaceuticals, Inc. Common Stock (ABOS) earnings history chevron_right
- Arbutus Biopharma Corp (ABUS) earnings history chevron_right
- ABVC BioPharma, Inc. Common Stock (ABVC) earnings history chevron_right
- ACADIA PHARMACEUTICALS INC (ACAD) earnings history chevron_right
- Adicet Bio, Inc. Common Stock (ACET) earnings history chevron_right
- Acadia Healthcare Company, Inc. Common Stock (ACHC) earnings history chevron_right
- Achieve Life Sciences, Inc. Common Shares (ACHV) earnings history chevron_right